Compare Diagnos Laboratorium Utama Tbk. (DGNS) vs Penta Valent Tbk. (PEVE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Diagnos Laboratorium Utama Tbk. vs Penta Valent Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp232 (market cap 319B, 600 24h volume), while Penta Valent Tbk. trades at Rp324 (market cap 572.06B, 5K 24h volume). The key difference: Penta Valent Tbk. is the larger of the two by market cap, and Penta Valent Tbk. is more actively traded (5K versus 600). Which is the better fit depends on your goals.
| DGNS | PEVE | |
|---|---|---|
Market Cap | 319B | 572.06B |
Volume | 600 | 5K |
Lot | 6 | 50 |
Turnover | 139.2K | 1.62M |
Average Price | 232 | 324 |
Value | 139.2K | 1.62M |
Indicative Equilibrium Price | 232 | 324 |
Indicative Equilibrium Volume | 200 | 5K |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Diagnos Laboratorium Utama Tbk.
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →About Penta Valent Tbk.
PT Penta Valent Tbk (the Company) was established in 1968 in Jakarta, Indonesia under the name of CV Penta Valent, hereinafter, based on Notarial Deed No. 48 of Bebasa Daeng Lalo, S.H., dated August 16, 1972. The Company started its commercial operations in 1968. PT Tancorp Global Sentosa, a company incorporated in Indonesia, is the ultimate parent entity of the Company.
Read more on PEVE →
